{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:27:06Z","timestamp":1758709626326,"version":"3.41.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mcna.2024.10.001","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T17:44:29Z","timestamp":1736012669000},"page":"401-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urgent Issues in Multiple Sclerosis"],"prefix":"10.1016","volume":"109","author":[{"given":"Methma","family":"Udawatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Matiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9936","key":"10.1016\/j.mcna.2024.10.001_bib1","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(13)62641-0","article-title":"Modifying disability in progressive multiple sclerosis","volume":"383","author":"Palace","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.mcna.2024.10.001_bib2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.mcna.2024.10.001_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.mcna.2024.10.001_bib4","first-page":"e1029","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data [published correction appears in Neurology. 2019 Oct 8;93(15):688]","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.mcna.2024.10.001_bib5","doi-asserted-by":"crossref","first-page":"e1818","DOI":"10.1212\/WNL.0000000000200151","article-title":"Racial and ethnic disparities in multiple sclerosis prevalence","volume":"98","author":"Langer-Gould","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12883-024-03598-z","article-title":"Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland","volume":"24","author":"Kuri","year":"2024","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.mcna.2024.10.001_bib7","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1212\/WNL.0000000000207481","article-title":"Global barriers to the diagnosis of multiple sclerosis: data from the multiple sclerosis international federation atlas of MS, third edition","volume":"101","author":"Solomon","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2024.10.001_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2010.02.007","article-title":"Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts","volume":"292","author":"Kingwell","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/biomedicines11041227","article-title":"Health disparities in multiple sclerosis among hispanic and black populations in the United States","volume":"11","author":"Moore","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.mcna.2024.10.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105508","article-title":"Disparities in DMT treatment: demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies","author":"Leavitt","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/13524585221129963","article-title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","volume":"29","author":"Calocer","year":"2023","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nic.2016.12.001","article-title":"Multiple sclerosis: epidemiologic, clinical, and therapeutic aspects","volume":"27","author":"Vidal-Jordana","year":"2017","journal-title":"Neuroimaging Clin N Am"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1941874412457183","article-title":"Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis","volume":"3","author":"Marcus","year":"2013","journal-title":"Neurohospitalist"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"Radiologically isolated syndrome: 10-year risk estimate of a clinical event","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mcna.2024.10.001_bib18","series-title":"Presented at ECTRIMS congress; september 18-20, 2024; Copenhagen, Denmark","article-title":"Revisions of the McDonald criteria","author":"Montalban","year":"2024"},{"issue":"9","key":"10.1016\/j.mcna.2024.10.001_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.mcna.2024.10.001_bib20","series-title":"StatPearls","article-title":"Lhermitte sign","author":"Teoli","year":"2024"},{"issue":"5","key":"10.1016\/j.mcna.2024.10.001_bib21","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1212\/NXI.0000000000000279","article-title":"The topographical model of multiple sclerosis: a dynamic visualization of disease course","volume":"3","author":"Krieger","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib22","first-page":"1","article-title":"Relapse management in multiple sclerosis","volume":"15","author":"Thrower","year":"2009","journal-title":"Neurol"},{"issue":"9997","key":"10.1016\/j.mcna.2024.10.001_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mcna.2024.10.001_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A\u00a0randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"7540","key":"10.1016\/j.mcna.2024.10.001_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bmj.332.7540.525","article-title":"Diagnosis and treatment of multiple sclerosis","volume":"332","author":"Murray","year":"2006","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib26","first-page":"988","article-title":"Epidemiology and pathophysiology of multiple sclerosis","volume":"28","author":"Ward","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40265-021-01650-7","article-title":"Ofatumumab: a review in relapsing forms of multiple sclerosis [published correction appears in drugs. 2021 dec 29","volume":"82","author":"Kang","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib28","doi-asserted-by":"crossref","first-page":"ofy356","DOI":"10.1093\/ofid\/ofy356","article-title":"Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis","volume":"6","author":"Ciardi","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2024.10.001_bib29","first-page":"3961","article-title":"Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus","volume":"268","author":"Centonze","year":"2021","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-024-02011-w","article-title":"Drugs targeting CD20 in multiple sclerosis: pharmacology, efficacy, safety, and tolerability","volume":"84","author":"Carlson","year":"2024","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1756285614563522","article-title":"Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use","volume":"8","author":"Havrdova","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"10.1016\/j.mcna.2024.10.001_bib32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/13524585231168043","article-title":"ECTRIMS\/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs","volume":"29","author":"Otero-Romero","year":"2023","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/WCO.0000000000000929","article-title":"Vaccinations in multiple sclerosis patients receiving disease-modifying drugs","volume":"34","author":"Otero-Romero","year":"2021","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000529982","article-title":"Summary of safety and efficacy of COVID vaccination in patients with multiple sclerosis","volume":"86","author":"Pernicov\u00e1","year":"2023","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mayocp.2021.11.010","article-title":"Preoperative management of medications for neurologic diseases: society for perioperative assessment and quality improvement consensus statement","volume":"97","author":"Oprea","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mcna.2024.10.001_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14737175.2021.1935878","article-title":"Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence","volume":"21","author":"Knippenberg","year":"2021","journal-title":"Expert Rev Neurother"},{"issue":"12","key":"10.1016\/j.mcna.2024.10.001_bib37","first-page":"2689","article-title":"Obesity and multiple sclerosis-A multifaceted association","volume":"10","author":"Schreiner","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamaneurol.2019.4271","article-title":"Association between cigarette smoking and multiple sclerosis: a review","volume":"77","author":"Rosso","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12883-021-02396-1","article-title":"Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review","volume":"21","author":"Oliva Ramirez","year":"2021","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib40","first-page":"CD002818","article-title":"Amantadine for fatigue in multiple sclerosis","volume":"2007","author":"Pucci","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2024.10.001_bib41","doi-asserted-by":"crossref","first-page":"113906","DOI":"10.1016\/j.expneurol.2021.113906","article-title":"Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil","volume":"347","author":"Cocco","year":"2022","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.mcna.2024.10.001_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/WNF.0000000000000572","article-title":"The utility of methylphenidate for fatigue in long-term neurological conditions: a meta-analytical review","volume":"46","author":"Hagan","year":"2023","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.mcna.2024.10.001_bib43","doi-asserted-by":"crossref","first-page":"103273","DOI":"10.1016\/j.msard.2021.103273","article-title":"Methylphenidate may improve mental fatigue in individuals with multiple sclerosis: a pilot clinical trial","volume":"56","author":"Natsheh","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00019052-199506000-00010","article-title":"Neuropsychology of multiple sclerosis","volume":"8","author":"Rao","year":"1995","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.mcna.2024.10.001_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1352458515591072","article-title":"A\u00a0comparison study of cognitive deficits in radiologically and clinically isolated syndromes","volume":"22","author":"Labiano-Fontcuberta","year":"2016","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.mcna.2024.10.001_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/1352458509105544","article-title":"Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study","volume":"15","author":"Patti","year":"2009","journal-title":"Mult Scler"},{"issue":"13","key":"10.1016\/j.mcna.2024.10.001_bib47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/1352458518803785","article-title":"Recommendations for cognitive screening and management in multiple sclerosis care","volume":"24","author":"Kalb","year":"2018","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pmr.2013.06.009","article-title":"Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis","volume":"24","author":"Pepping","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.mcna.2024.10.001_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7224\/1537-2073.2019-030","article-title":"Prevalence of lower urinary tract symptoms in people with multiple sclerosis: a systematic review and meta-analysis","volume":"22","author":"Al Dandan","year":"2020","journal-title":"Int J MS Care"},{"key":"10.1016\/j.mcna.2024.10.001_bib50","doi-asserted-by":"crossref","first-page":"102462","DOI":"10.1016\/j.msard.2020.102462","article-title":"Urinary tract infection in patients with multiple sclerosis: an overview","volume":"46","author":"Medeiros Junior","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4081\/aiua.2022.4.492","article-title":"Efficacy of overactive neurogenic bladder treatment: a systematic review of randomized controlled trials","volume":"94","author":"Bapir","year":"2022","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.mcna.2024.10.001_bib52","doi-asserted-by":"crossref","first-page":"103559","DOI":"10.1016\/j.msard.2022.103559","article-title":"Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: a systematic review and meta-analysis","volume":"59","author":"Kajbafvala","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"10.1016\/j.mcna.2024.10.001_bib53","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/14656566.2020.1767068","article-title":"Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients [published correction appears in Expert Opin Pharmacother. 2020 Jun 26;:1]","volume":"21","author":"Zangh\u00ec","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"5\u20136","key":"10.1016\/j.mcna.2024.10.001_bib54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000480729","article-title":"Multiple sclerosis and clinical gait analysis before and after fampridine: a systematic review","volume":"78","author":"Lecat","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.mcna.2024.10.001_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.22240","article-title":"A\u00a0phase 3 trial of extended release oral dalfampridine in multiple sclerosis","volume":"68","author":"Goodman","year":"2010","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.mcna.2024.10.001_bib56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cns.12101","article-title":"Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)","volume":"19","author":"Preiningerova","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pmr.2013.07.002","article-title":"Gait impairment and optimizing mobility in multiple sclerosis","volume":"24","author":"Stevens","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12883-017-0960-9","article-title":"Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations","volume":"17","author":"Halabchi","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.mcna.2024.10.001_bib59","doi-asserted-by":"crossref","first-page":"104629","DOI":"10.1016\/j.msard.2023.104629","article-title":"Effects of music therapy intervention on gait disorders in persons with multiple sclerosis: a systematic review of clinical trials","volume":"73","author":"Kong","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.mcna.2024.10.001_bib60","series-title":"Spasticity: disordered motor control","first-page":"485","article-title":"Symposium synopsis","author":"Lance","year":"1980"},{"issue":"4","key":"10.1016\/j.mcna.2024.10.001_bib61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pmr.2013.07.003","article-title":"Spasticity management in multiple sclerosis","volume":"24","author":"Hughes","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"11","key":"10.1016\/j.mcna.2024.10.001_bib62","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1177\/1352458516643600","article-title":"Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper","volume":"22","author":"Otero-Romero","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.mcna.2024.10.001_bib63","doi-asserted-by":"crossref","first-page":"799698","DOI":"10.3389\/fneur.2021.799698","article-title":"Pain in multiple sclerosis: understanding pathophysiology, diagnosis, and management through clinical vignettes","volume":"12","author":"Racke","year":"2022","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40263-024-01072-5","article-title":"Pharmacological and non-pharmacological approaches for the management of neuropathic pain in multiple sclerosis","volume":"38","author":"Shkodina","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mcna.2024.10.001_bib65","series-title":"StatPearls","article-title":"Uhthoff phenomenon","author":"Panginikkod","year":"2022"},{"key":"10.1016\/j.mcna.2024.10.001_bib66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.mcna.2024.10.001_bib67","first-page":"CD007295","article-title":"Pharmacologic treatment of depression in multiple sclerosis","volume":"2","author":"Koch","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.mcna.2024.10.001_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.mcna.2024.10.001_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ncl.2023.07.004","article-title":"Women's health and pregnancy in multiple sclerosis","volume":"42","author":"Bove","year":"2024","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib71","first-page":"12","article-title":"Pregnancy management in multiple sclerosis and other demyelinating diseases","volume":"28","author":"Bove","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.mcna.2024.10.001_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414568185","article-title":"Nutrition facts in multiple sclerosis","volume":"7","author":"Riccio","year":"2015","journal-title":"ASN Neuro"},{"issue":"6","key":"10.1016\/j.mcna.2024.10.001_bib73","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/nu14061150","article-title":"The role of diet and interventions on multiple sclerosis: a review","volume":"14","author":"Stoiloudis","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.mcna.2024.10.001_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3945\/an.116.014191","article-title":"Influence of diet in multiple sclerosis: a systematic review","volume":"8","author":"Bagur","year":"2017","journal-title":"Adv Nutr"},{"issue":"9","key":"10.1016\/j.mcna.2024.10.001_bib75","first-page":"CD009956","article-title":"Exercise therapy for fatigue in multiple sclerosis","volume":"2015","author":"Heine","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2024.10.001_bib76","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3389\/fimmu.2019.02954","article-title":"Multiple sclerosis and cancer: the ying-yang effect of disease modifying therapies","volume":"10","author":"Melamed","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.mcna.2024.10.001_bib77","doi-asserted-by":"crossref","first-page":"104798","DOI":"10.1016\/j.msard.2023.104798","article-title":"Association between multiple sclerosis and cancer risk: an extensive review\/meta and Mendelian randomization analyses","volume":"76","author":"Liu","year":"2023","journal-title":"Mult Scler Relat Disord"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T12:14:13Z","timestamp":1749298453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712524001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0025712524001275"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2024.10.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urgent Issues in Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}